Performance of the Abbott RealTime HCV Genotype II RUO Assay
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 • 3,083 citations
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 • 2,514 citations
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
2011 • 2,404 citations
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
2006 • 1,978 citations
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
2011 • 1,612 citations
Telaprevir for Retreatment of HCV Infection
2011 • 1,559 citations
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing
1995 • 229 citations
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers
2005 • 212 citations
Management and Treatment of Hepatitis C Viral Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
2006 • 169 citations
Boceprevir and Telaprevir in the Management of Hepatitis C Virus-Infected Patients
2011 • 97 citations
Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
2012 • 83 citations
A multicenter evaluation of the Abbott RealTime HCV Genotype II assay
2010 • 31 citations
Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping
2010 • 18 citations
Natural history of hepatitis C infection: a concise review.
2001 • 13 citations
Cited By (0)
No citing papers found in database